Webinar on Repurposing in a crisis: Tackling the COVID-19 wildfire on June 2, 2020

While the race for a vaccine targeting the SARS-CoV-2 coronavirus is expected to take another year or so, there is an increasingly urgent need to fight the disease in those already infected. Our upcoming webinar on COVID-19 will tackle the unique challenges of accelerating drug development by repurposing existing therapies where each day missed equals lives lost.

Speaker Information:

Nevan Krogan headshot-1

Nevan Krogan, PhD
Professor, Cellular & Molecular Pharmacology, University of California, San Francisco
Director, Quantitative Biosciences Institute, UCSF School of Pharmacy

SARS-CoV-2 protein interaction map reveals targets for drug repurposing

To find antiviral drugs versus SARS-CoV-2, it helps to understand how viral and human proteins interact.

DDN_COVID Webinar_200602_Sumit Chanda

Sumit Chanda, PhD
Director, Immunity & Pathogenesis Program, Sanford Burnham Presbys Medical Discovery Institute

Identifying inhibitors of SARS-CoV-2 replication by profiling a library of known drugs

To potentially shorten the development of antivirals against COVID-19, it is helpful to start with a panel of well-characterized leads.

Sponsored by

ProQinase -Covid - Webinar -June 2 2020.png

Interested in sponsoring a webinar?
Click here to contact our friendly sales team.